Q2B25 Paris | Pharmaceutical Panel @QCWare
Q2B25 Paris | Pharmaceutical Panel  @QCWare
Uploaded October 2025 | Updated September 2026, 2 weeks ago
Stefan Ostermann, Quantum Applications Manager, QuEra Computing Inc. and
Anders Broo, Executive Director, Head of Data Science & Modelling AstraZeneca and
Shihan Sajeed, Program Director, Wellcome Leap and
Michael Stivaktakis, Quantum & AI Researcher, Merck Group and
Matthias Degroote, Applied Quantum Computing Scientist Boehringer Ingelheim

q2b.qcware.com
Q2B25 Paris | Pharmaceutical PanelQ2B26 Tokyo | Masako Yamada, Senior Director Applications and Mei Maruo, Senior Physicist, IonQQ2B25 Paris | Aaron Trowbridge, CEO, HarmoniqsQ2B25 Silicon Valley | Quantum Technologies: Innovation and Investment PanelQ2B25 Silicon Valley | Shmuel Bachinsky, CEO, Quantum TransistorsQ2B25 Silicon Valley | David Rivas, CTO, RigettiQ2B25 Paris | Cierra Choucair, Director of Strategic Content, TQIQ2B25 Silicon Valley | Kevin Kissell, Eminence Grise, Alice & BobQ2B25 Silicon Valley | Dr. Bob Sutor, CEO & Founder, Sutor Group Intelligence and AdvisoryQ2B26 Tokyo | Akira Tanaka, Managing Director, APAC, Classiq TechnologiesQ2B26 Tokyo | Gilad-Ben Shach, Quantum Machines and Denis Chevallier, Horizon QuantumQ2B25 Silicon Valley | Helmut Katzgraber, CSO & General Partner, 55 North
QC Ware |

Q2B25 Paris | Pharmaceutical Panel

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER